SPOTLIGHT: Novartis taps new U.S. pharma chief

The musical chairs game in Novartis' top management ranks is continuing as new pharma chief Joe Jiminez revamps the ranks. The Swiss drug maker has appointed Ludwig Hantson to top its U.S. pharmaceuticals business. Hantson takes over for Alex Gorsky, whose departure was announced in February; previously, Hantson ran Novartis' European pharma business. Report

Suggested Articles

Paragon Biosciences has hired Kerensa Jimenez as the new CEO of its capital markets group Paragon Health Capital.

Regeneron has taken a step closer to getting a green light for its experimental high cholesterol drug as the FDA allows a swift review of evicanumab.

An analysis of Gilead’s remdesivir clinical trials found the studies “failed to provide equal representation of Black, Latinx and Native Americas."